1.0 Funding Use Questions

Operational Intent:These questions will be asked of each funded recipient and sub-recipient to determine which performance measures they should respond to. Recipients and sub-recipients will only be asked to provide data for those performance measures that correspond to the outcomes and activities for which they used RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funds.

1.1 Funding by Recipient

Recipients must report the funding amount provided to each sub-recipient. Recipients must limit their direct costs (excluding subawards to RESPTCs) to no more than 10 percent of the allocation. ASPR will consider requests for exemptions on a case-by-case basis.

Program Performance Measure	Data Point(s)	Data Entity	Calculation
PM 1: Total amount of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding provided andamount provided to RESPTCs (Recipient level allowable direct cost cannot exceed 10%)	Total amount of funding provided to recipient will be prepopulated Tranche 1: Please indicate the amount of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding (in whole dollars) provided to your RESPTC using the first tranche of this funding. Tranche 2: Please indicate the amount of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding (in whole dollars) provided to your RESPTC using the second tranche of this funding.	Recipient	Recipient-level direct cost = (amount of funding in whole dollars retained by the recipient for activities and funding management / total recipient funding) x 100%
PM 2: Number of calendar days from the start of the award for recipients to execute RESPTC sub-awards	Tranche 1: Please indicate the date on which your RESPTC’s sub-award was executed for the first tranche of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding. Tranche 2: Please indicate the date on which your RESPTC’s sub-award was executed for the second tranche of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding.	Recipient	Number of days to execute subaward = (date subaward executed – date of notice of award)

Program Performance Measure

Data Point(s)

Data Entity

Calculation

PM 1: Total amount of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding provided andamount provided to RESPTCs (Recipient level allowable direct cost cannot exceed 10%)

Total amount of funding provided to recipient will be prepopulated

Tranche 1: Please indicate the amount of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding (in whole dollars) provided to your RESPTC using the first tranche of this funding.

Tranche 2: Please indicate the amount of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding (in whole dollars) provided to your RESPTC using the second tranche of this funding.

Recipient

Recipient-level direct cost = (amount of funding in whole dollars retained by the recipient for activities and funding management / total recipient funding) x 100%

PM 2: Number of calendar days from the start of the award for recipients to execute RESPTC sub-awards

Tranche 1: Please indicate the date on which your RESPTC’s sub-award was executed for the first tranche of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding.

Tranche 2: Please indicate the date on which your RESPTC’s sub-award was executed for the second tranche of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding.

Recipient

Number of days to execute subaward = (date subaward executed – date of notice of award)

1.2 Estimated Funding by Target Outcomes

RESPTCs are to select the target outcomes (one or more) that the RESPTC directly used funding for from the RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement. For each targeted outcome for which the RESPTC used funding from this COVID-19-specific administrative supplement, indicate the estimated number of funding dollars used for the associated outcome. Please leave all other sections blank. Responses to this question are only used to determine which performance measures will be reported by the sub-recipient and do not replace other financial reporting requirements outlined in 45 CFR 75.

PM 3: Estimated COVID-19 Supplemental Funding by Target Outcome

Targeted Outcome	Estimated number of dollars of RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement funding used for associated activities:
Continue to address preparedness and readiness gaps for RESPTCs and other health care facilities by making improvements in the following areas: With attention to supply chain shortages, maintain appropriate stores and types of personal protective equipment (PPE), in accordance with CDC guidelines Provide clinical recommendations, protocols, and standards of care for treating patients, including experimental protocols and crisis standards of care Implement operational guidance and share promising practices for health care worker safety, including developing training opportunities for staff members outside of the immediate COVID-19 team to improve infection control measures, including PPE donning and doffing techniques Plan for coordinating in a medical surge event including how to screen patients for symptoms, rapidly isolate patients, provide PPE, and interfacility transport, if necessary Transition ambulatory surgery centers to inpatient care (especially if they have vents or anesthesia equipment and monitors in post-anesthesia care units) for higher acuity patients Identify alternate care sites (on facility grounds or within close proximity) and additional sites (offsite) for sub-acute care patients to increase capacity Improve the transport of laboratory specimens to testing laboratories Further develop plans for the segregation, storage, and processing of biohazardous waste Improve recruitment and retention of special pathogen trained staff with specialties that may be needed in COVID-19 and future special pathogens responses, including pediatrics, geriatrics, pulmonologists, and intensivists Develop specific plans for at-risk populations, including homeless, older adults, individuals with chronic conditions, undocumented individuals, children, pregnant women, and individuals with disabilities, focusing on at-risk populations with increased morbidity and mortality from COVID-19 Increase the capacity for all regional treatment centers to conduct clinical trials for medical countermeasures and research the spread and transmission of COVID-19 and other special pathogens Expand travel history and symptom screening processes to points of entry other than/in addition to emergency department triage and registration areas
Regional treatment centers’ maintenance of their continued capability and capacity for COVID-19 care
Continue to use novel approaches for education, readiness, and assessment activities to support COVID-19 response, including expanding the use of media, augmented reality/virtual reality, and technology to enhance training for staff and providing National Emerging Special Pathogens Training and Education Center (NETEC) training and materials to health care facilities throughout the region (acting in a ‘train the trainer’ capacity)
Support continued planning, development, and implementation of a national system for special pathogen patient care, including engaging state and jurisdiction special pathogen treatment centers and other health care facilities (including but not limited to settings such as nursing homes, residential care facilities, EMS, and 911 call centers). This network may be informed by and modeled using the lessons learned from already established trauma, stroke, or burn specialty networks
Support NETEC in their activities as a ‘force amplifier’ in their region
Collect RESPTC evaluation and performance measures for COVID-19, in addition to receiving peer assessments using metrics developed by the National Emerging Special Pathogens Training and Education Center (NETEC)
Conduct supplemental training for health care facility workers and awareness trainings to health care entities outside the acute health care system on COVID-19 patient identification, assessment, and treatment
Develop and implement a 24-hour hotline and other resources (e.g., telemedicine, use of alternative care sites, etc.) to support clinical consultation and technical assistance for COVID-19
Ensure a physician is in the state or jurisdiction emergency operations center full time to manage patient facility assignments (right bed for the right patient) within their state or jurisdiction so that EMS and hospitals do not need to transfer patients; for example, participating in or establishing a Medical Operations Coordinating Cell (MOCC)

<< Previous --------- Top of Page --------- Next >>

This page last reviewed: April 08, 2021